CoChat
Sign Up
Cited by 295

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Rapamycin is a neuroprotective treatment for traumatic brain injury

Erlich, S., Alexandrovich, A., Shohami, E., Pinkas-Kramarski, R.·2007·Neurobiology of Disease
DOI 10.1016/j.nbd.2006.12.003
Open this paper in CoChat — free account

Abstract

The mammalian target of rapamycin, commonly known as mTOR, is a serine/threonine kinase that regulates translation and cell division. mTOR integrates input from multiple upstream signals, including growth factors and nutrients to regulate protein synthesis. Inhibition of mTOR leads to cell cycle arrest, inhibition of cell proliferation, immunosuppression and induction of autophagy. Autophagy, a bulk degradation of sub-cellular constituents, is a process that keeps the balance between protein synthesis and protein degradation and is induced upon amino acids deprivation. Rapamycin, mTOR signaling inhibitor, mimics amino acid and, to some extent, growth factor deprivation. In the present study we examined the effect of rapamycin, on the outcome of mice after brain injury. Our results demonstrate that rapamycin injection 4 h following closed head injury significantly improved functional recovery as manifested by changes in the Neurological Severity Score, a neurobehavioral testing. To verify the activity of the injected rapamycin, we demonstrated that it inhibits p70S6K phosphorylation, reduces microglia/macrophages activation and increases the number of surviving neurons at the site of injury. We therefore suggest that rapamycin is neuroprotective following traumatic brain injury and as a drug used in the clinic for other indications, we propose that further studies on rapamycin should be conducted in order to consider it as a novel therapy for traumatic brain injury.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2006.12.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In yeast, dephosphorylation of Atg13 is associated with activation/assembly of the core complex that reflects the reduction of TORC1 and PKA activities.

    “In yeast, dephosphorylation of Atg13 is associated with activation/assembly of the core complex that reflects the reduction of TORC1 and PKA activities.”

    From Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 (2021) · cites this paper as [737]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. Baker, 1978, Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation, J. Antibiot., 31, 539, 10.7164/antibiotics.31.539 · DOI
  2. Beni-Adani, 2001, A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice, J. Pharmacol. Exp. Ther., 298, 57, 10.1016/S0022-3565(24)29662-2 · DOI
  3. Berger, 2006, Rapamycin alleviates toxicity of different aggregate-prone proteins, Hum. Mol. Genet., 15, 433, 10.1093/hmg/ddi458 · DOI · Paper page
  4. Blommaart, 1995, Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes, J. Biol. Chem., 270, 2320, 10.1074/jbc.270.5.2320 · DOI · Paper page
  5. Chen, 1996, An experimental model of closed head injury in mice: pathophysiology, histopathology and cognitive deficits, J. Neurotrauma, 13, 557, 10.1089/neu.1996.13.557 · DOI
  6. Diskin, 2005, Closed head injury induces upregulation of beclin 1 at the cortical site of injury, J. Neurotrauma, 22, 750, 10.1089/neu.2005.22.750 · DOI
  7. Dutcher, 2004, Mammalian target of rapamycin inhibition, Clin Cancer Res., 10, 6382S, 10.1158/1078-0432.CCR-050008 · DOI
  8. Erlich, 2000, Closed head injury induces upregulation of ErbB-4 receptor at the site of injury, Mol. Cell. Neurosci., 16, 597, 10.1006/mcne.2000.0894 · DOI
  9. Erlich, 2006, Neurodegeneration induces up regulation Beclin 1, Autophagy, 2, e4, 10.4161/auto.2156 · DOI
  10. Faden, 1993, Experimental neurobiology of central nervous system trauma, Crit. Rev. Neurobiol., 7, 175
  11. Guba, 2002, Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor, Nat. Med., 8, 128, 10.1038/nm0202-128 · DOI
  12. Harris, 2003, TOR signaling, Sci STKE., re15
  13. Hay, 2004, Upstream and downstream of mTOR, Genes Dev., 1926, 10.1101/gad.1212704 · DOI · Paper page
  14. Kamada, 2004, Autophagy in yeast: a TOR-mediated response to nutrient starvation, Curr. Top. Microbiol. Immunol., 279, 73
  15. Kirino, 2000, Delayed neuronal death, Neuropathology, 20, S95, 10.1046/j.1440-1789.2000.00306.x · DOI
  16. Klionsky, 2000, Autophagy as a regulated pathway of cellular degradation, Science, 290, 1717, 10.1126/science.290.5497.1717 · DOI
  17. Koehl, 2004, Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice, Transplantation, 77, 1319, 10.1097/00007890-200405150-00002 · DOI
  18. Komatsu, 2006, Loss of autophagy in the central nervous system causes neurodegeneration in mice, Nature, 441, 880, 10.1038/nature04723 · DOI · Paper page
  19. Larsen, 2002, Autophagy in neurons: a review, Histol. Histopathol., 17, 897
  20. Leker, 2002, Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities, Brain Res. Brain Res. Rev., 39, 55, 10.1016/S0165-0173(02)00157-1 · DOI
  21. Martel, 1977, Inhibition of the immune response by rapamycin, a new antifungal antibiotic, Can J. Physiol. Pharmacol., 55, 48, 10.1139/y77-007 · DOI
  22. Noda, 1998, Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast, J. Biol. Chem., 273, 3963, 10.1074/jbc.273.7.3963 · DOI
  23. Ogier-Denis, 2003, Autophagy: a barrier or an adaptive response to cancer, Biochim. Biophys. Acta, 603, 113
  24. Olsen, 1994, Rapamycin inhibits corneal allograft rejection and neovascularization, Arch. Ophthalmol., 112, 1471, 10.1001/archopht.1994.01090230085026 · DOI
  25. Pekny, 2005, Astrocyte activation and reactive gliosis, Glia, 50, 427, 10.1002/glia.20207 · DOI · Paper page
  26. Pinkas-Kramarski, 1997, Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation, Oncogene, 15, 2803, 10.1038/sj.onc.1201466 · DOI
  27. Proud, 2004, mTOR-mediated regulation of translation factors by amino acids, Biochem. Biophys. Res. Commun., 313, 429, 10.1016/j.bbrc.2003.07.015 · DOI
  28. Ravikumar, 2004, Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?, NeuroReport, 15, 2443, 10.1097/00001756-200411150-00001 · DOI
  29. Ravikumar, 2002, Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy, Hum. Mol. Genet., 11, 1107, 10.1093/hmg/11.9.1107 · DOI
  30. Reggiori, 2002, Autophagy in the eukaryotic cell, Eukaryot. Cell, 1, 11, 10.1128/EC.01.1.11-21.2002 · DOI
  31. Schmelzle, 2000, TOR, a central controller of cell growth, Cell, 103, 253, 10.1016/S0092-8674(00)00117-3 · DOI
  32. Shigemitsu, 1999, Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells, J. Biol. Chem., 274, 1058, 10.1074/jbc.274.2.1058 · DOI
  33. Shohami, 1999, Dual role of tumor necrosis factor alpha in brain injury, Cytokine Growth Factor Rev., 10, 119, 10.1016/S1359-6101(99)00008-8 · DOI
  34. Sousa, 2003, Use of rapamycin-impregnated stents in coronary arteries, Transplant. Proc., 35, 165S, 10.1016/S0041-1345(03)00215-X · DOI
  35. Vignot, 2005, mTOR-targeted therapy of cancer with rapamycin derivatives, Ann. Oncol., 16, 525, 10.1093/annonc/mdi113 · DOI
  36. Wang, 2003, The molecular mechanism of autophagy, Mol. Med., 9, 65, 10.1007/BF03402040 · DOI
  37. Yatsiv, 2005, Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury, FASEB J., 12, 1701, 10.1096/fj.05-3907fje · DOI

Cited by

Sorted by citations

Metadata

Authors
Erlich, S., Alexandrovich, A., Shohami, E., & Pinkas-Kramarski, R.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2007-04
Volume
26
Issue
1
Pages
86-93
ISSN
0969-9961
DOI
10.1016/j.nbd.2006.12.003
Cited by
295
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review